Effect of Neurosed syrup on ADHD

? Evaluation of therapeutic effects of Neurosed syrup on the clinical symptoms of children with ADHD -A randomized double blind trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230718058834N1

Enrollment

Registered

2023-11-21

Start date

2023-12-01

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder (ADHD). Attention-deficit hyperactivity disorder, predominantly inattentive type

Interventions

Intervention 1: Intervention group: A number of 25 children aged 5-12 years with ADHD referred to Imam Ali Shahrekord clinic, who will use Neurosed syrup, which contains Melissa Officinalis extract an

Eligibility

Sex/Gender

All

Age

5 Years to 12 Years

Inclusion criteria

Inclusion criteria: Children with ADHD The age of people should be 5-12 years

Exclusion criteria

Exclusion criteria: Use of Barbiturates, drugs that suppress the central nervous system, and blood sugar-lowering drugs Presence of other concurrent diseases

Design outcomes

Primary

Measure	Time frame
ADHD score according to Conners parent questionnaire. Timepoint: Before the start of the intervention and one month after consuming Neurosed syrup. Method of measurement: Conners parent questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Torabi

Shahre-kord University of Medical Sciences

torabimaryam75@gmail.com038322220016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026